Phase II clinical trial results demonstrated: Body weight reduction of up to 2% at 48 weeks ( vs 2.1% placebo ) 83% of participants achieved 15% body weight loss at highest dose HbA1c reduction of up to 02% in Type 2 Diabetes participants ( vs 0% placebo ) Normalization of liver fat in 86% of participants with hepatic steatosis Reduction in systolic blood pressure averaging 6-8 mmHg These Phase II findings are preliminary
Uses of semaglutide The FDA explains, that doctors may prescribe semaglutide in combination with an appropriate diet and exercise program to help control blood sugar levels in adults with type 2 diabetes
The biology, in short, is where the next generation of these drugs will be designed
Mechanism of action: Activates GLP-1 receptors in the brain, gut, and pancreas Reduces appetite and food cravings Slows gastric emptying you feel full longer Stimulates insulin release, suppresses glucagon Improves blood sugar regulation FDA-approved brand names: Wegovy 2.4mg weekly, approved for chronic weight management Ozempic approved for type 2 diabetes
In my clinic, I often see clients who have reached a point where they can no longer distinguish between physical hunger and mental noise
